Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time as a Clinical Variable. Translational Medicine & Therapeutics Journal, [S. l.], v. 2, n. 1, p. 1–9, 2023. DOI: 10.5281/zenodo.22649019. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/77. Acesso em: 5 nov. 2026.